APA (7th ed.) Citation

Ma, C., Chang, J., & Yu, B. Sunlenca® (Lenacapavir): A first-in-class, long-acting HIV-1 capsid inhibitor for treating highly multidrug-resistant HIV-1 infection. Elsevier.

Chicago Style (17th ed.) Citation

Ma, Chunhua, Junbiao Chang, and Bin Yu. Sunlenca® (Lenacapavir): A First-in-class, Long-acting HIV-1 Capsid Inhibitor for Treating Highly Multidrug-resistant HIV-1 Infection. Elsevier.

MLA (9th ed.) Citation

Ma, Chunhua, et al. Sunlenca® (Lenacapavir): A First-in-class, Long-acting HIV-1 Capsid Inhibitor for Treating Highly Multidrug-resistant HIV-1 Infection. Elsevier.